Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300398	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	License Renew	2023-10-13		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH;Pfizer Investment Co Ltd			view
JYHZ2300397	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	License Renew	2023-10-13		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH;Pfizer Investment Co Ltd			view
JYHB2400694	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2025-01-01		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2400693	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2025-01-01		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2300482	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2023-08-29		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2300481	达可替尼片	dacomitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2023-08-29		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2101388	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-09-01		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2101387	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-09-01		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2101073	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-05-13		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2101072	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-05-13		Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH			view
JYHB2001900	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2020-09-29	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH	Filed	2020-10-16	view
JYHB2001899	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2020-09-29	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH	Filed	2020-10-16	view
JYHB1901428	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-12-04	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH	Certificate Issued	2020-01-02	view
JYHB1901427	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-12-04	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH	Certificate Issued	2020-01-02	view
JYHB1901170	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-09-23	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd	Filed	2019-10-08	view
JYHB1901169	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-09-23	辉瑞投资有限公司	Pfizer Investment Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd	Filed	2019-10-08	view
JXHS1800024	Dacomitinib片	dacomitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2018-05-21	辉瑞制药有限公司	Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd	Certificate Issued	2019-05-17	view
JXHS1800023	Dacomitinib片	dacomitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2018-05-21	辉瑞制药有限公司	Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd	Certificate Issued	2019-05-17	view
JXHL1300031	PF-00299804片	dacomitinib	Tablet	Chemical Drugs	Import Drug Application	2013-01-30	辉瑞制药有限公司	Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Inc	Certificate Issued	2013-09-29	view
JXHL1300030	PF-00299804片	dacomitinib	Tablet	Chemical Drugs	Import Drug Application	2013-01-30	辉瑞制药有限公司	Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Inc	Certificate Issued	2013-09-29	view